Profile http://med.stanford.edu/profiles/Jose_Montoya/ Email this page Printer friendly version

Key Documents

Jose G. Montoya

Associate Professor - Med Center Line, Medicine - Infectious Diseases

Contact Information

Clinical Offices

Infectious Disease Clinic 300 Pasteur Dr A175 MC 5309 Stanford, CA 94305
Telephone Work (650) 723-6961 Fax (650) 725-8418
Academic Offices

Personal Information

Administrative Contact
Anika Mshuja Executive Assistant Email mshujaa@pamfri.org Tel Work 6508534824

Not for medical emergencies or patient use

Clinical Focus

Infectious Disease
Immunocompromised Host
Toxoplasmosis

Administrative Appointments

Director, National Reference Laboratory for the Study and Diagnosis of Toxoplasmosis , (2008– present )

Professional Education

Tulane University School of Medicine (1990) LA
Tulane University School of Medicine (1988) LA
SUMC - Graduate Medical Education (1994) CA
Universidad Del Valle (1985) Colombia

Graduate & Fellowship Program Affiliations

Infectious Diseases

Clinical Trials

Phase III of 2 Dosing Regimens of Caspofungin in the Treatment of Invasive Candidiasis in Adults Completed

Publications

Yield of diagnostic procedures for invasive fungal infections in neutropenic febrile patients with chest computed tomography abnormalities. Ho DY, Lin M, Schaenman J, Rosso F, Leung AN, Coutre SE, Sista RR, Montoya JG. Mycoses. 2009;
Trends in invasive disease due to Candida species following heart and lung transplantation. Schaenman JM, Rosso F, Austin JM, Baron EJ, Gamberg P, Miller J, Oyer PE, Robbins RC, Montoya JG. Transpl Infect Dis. 2009; 11 (2): 112-21
Challenges and pitfalls of morphologic identification of fungal infections in histologic and cytologic specimens: a ten-year retrospective review at a single institution. Sangoi AR, Rogers WM, Longacre TA, Montoya JG, Baron EJ, Banaei N. Am J Clin Pathol. 2009; 131 (3): 364-75
Changing Trends in Infectious Disease in Heart Transplantation. Haddad F, Deuse T, Pham M, Khazanie P, Rosso F, Luikart H, Valantine H, Leon S, Vu TA, Hunt SA, Oyer P, Montoya JG. J Heart Lung Transplant. 2009;
Risk factors for Toxoplasma gondii infection in the United States. Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. Clin Infect Dis. 2009; 49 (6): 878-84
Prevention and treatment of cancer-related infections. Segal BH, Freifeld AG, Baden LR, Brown AE, Casper C, Dubberke E, Gelfand M, Greene JN, Ison MG, Ito JI, Karp JE, Kaul DR, King E, Mackler E, Marcucci G, Montoya JG, Engemann AM, Rolston K, The AS. J Natl Compr Canc Netw. 2008; 6 (2): 122-74
Management of Toxoplasma gondii infection during pregnancy. Montoya JG, Remington JS. Clin Infect Dis. 2008; 47 (4): 554-66
Prevalence of infection with Toxoplasma gondii among pregnant women in Cali, Colombia, South America. Rosso F, Les JT, Agudelo A, Villalobos C, Chaves JA, Tunubala GA, Messa A, Remington JS, Montoya JG. Am J Trop Med Hyg. 2008; 78 (3): 504-8
Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with foscarnet plus ganciclovir. Troy SB, Blackburn BG, Yeom K, Caulfield AK, Bhangoo MS, Montoya JG. Clin Infect Dis. 2008; 47 (12): e93-6
A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient. Walia R, Montoya JG, Visvesvera GS, Booton GC, Doyle RL. Transpl Infect Dis. 2007; 9 (1): 51-4
Pulmonary nocardiosis in a heart transplant patient: case report and review of the literature. Haddad F, Hunt SA, Perlroth M, Valantine H, Doyle R, Montoya J. J Heart Lung Transplant. 2007; 26 (1): 93-7
The differential agglutination test as a diagnostic aid in cases of toxoplasmic lymphadenitis. Montoya JG, Berry A, Rosso F, Remington JS. J Clin Microbiol. 2007; 45 (5): 1463-8
Treating disseminated fusariosis: amphotericin B, voriconazole or both? Ho DY, Lee JD, Rosso F, Montoya JG. Mycoses. 2007; 50 (3): 227-31
Improving the tools in the fight against cytomegalovirus or strengthening David to defeat Goliath. Montoya JG, Curr Opin Infect Dis. 2007; 20 (4): 397-8
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Singh N, Limaye AP, Forrest G, Safdar N, Muñoz P, Pursell K, Houston S, Rosso F, Montoya JG, Patton P, Del Busto R, Aguado JM, Fisher RA, Klintmalm GB, Miller R, Wagener MM, Lewis RE, Kontoyiannis DP, Husain S. Transplantation. 2006; 81 (3): 320-6
Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. Kogelnik AM, Loomis K, Hoegh-Petersen M, Rosso F, Hischier C, Montoya JG. J Clin Virol. 2006; 37 Suppl 1 S33-8
Late-onset invasive aspergillosis in organ transplant recipients in the current era. Singh N, Limaye AP, Forrest G, Safdar N, Muñoz P, Pursell K, Houston S, Rosso F, Montoya JG, Patton PR, Del Busto R, Aguado JM, Wagener MM, Husain S. Med Mycol. 2006; 44 (5): 445-9
Is combination therapy indicated for invasive fungal infections? Yes and no. Montoya JG, Rosso F. Curr Opin Infect Dis. 2006; 19 (4): 357-9
Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan EL, Montoya JG, Wade JC. Clin Infect Dis. 2005; 41 (10): 1373-406
Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adults. Press C, Montoya JG, Remington JS. J Clin Microbiol. 2005; 43 (7): 3481-3
Molecular mycological diagnosis and correct antimycotic treatments. Mancini N, Ossi CM, Perotti M, Clementi M, Digiulio DB, Schaenman JM, Montoya JG, McClenny NB, Berry GJ, Mirels LF, Rinaldi MG, Fothergill AW. J Clin Microbiol. 2005; 43 (7): 3584; author reply 3584-5
Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy. Schaenman JM, Digiulio DB, Mirels LF, McClenny NM, Berry GJ, Fothergill AW, Rinaldi MG, Montoya JG. J Clin Microbiol. 2005; 43 (2): 973-7
Diagnosis and management of toxoplasmosis. Montoya JG, Rosso F. Clin Perinatol. 2005; 32 (3): 705-26
Successes and limitations of antimicrobial interventions in the setting of organ transplantation. Montoya JG, Curr Opin Infect Dis. 2004; 17 (4): 341-5
Evaluation of the immunoglobulin G avidity test for diagnosis of toxoplasmic lymphadenopathy. Montoya JG, Huffman HB, Remington JS. J Clin Microbiol. 2004; 42 (10): 4627-31
Toxoplasmosis. Montoya JG, Liesenfeld O. Lancet. 2004; 363 (9425): 1965-76
Recent developments for diagnosis of toxoplasmosis. Remington JS, Thulliez P, Montoya JG. J Clin Microbiol. 2004; 42 (3): 941-5
Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University. Gao SZ, Chaparro SV, Perlroth M, Montoya JG, Miller JL, DiMiceli S, Hastie T, Oyer PE, Schroeder J. J Heart Lung Transplant. 2003; 22 (5): 505-14
Invasive aspergillosis in the setting of cardiac transplantation. Montoya JG, Chaparro SV, Celis D, Cortés JA, Leung AN, Robbins RC, Stevens DA. Clin Infect Dis. 2003; 37 Suppl 3 S281-92
VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. Montoya JG, Liesenfeld O, Kinney S, Press C, Remington JS. J Clin Microbiol. 2002; 40 (7): 2504-8
Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage therapy. Kantor R, Fessel WJ, Zolopa AR, Israelski D, Shulman N, Montoya JG, Harbour M, Schapiro JM, Shafer RW. Antimicrob Agents Chemother. 2002; 46 (4): 1086-92
Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. Montoya JG, J Infect Dis. 2002; 185 Suppl 1 S73-82
Brain abscess due to Listeria monocytogenes: five cases and a review of the literature. Eckburg PB, Montoya JG, Vosti KL. Medicine (Baltimore). 2001; 80 (4): 223-35
Paclitaxel-induced hypersensitivity pneumonitis: radiographic and CT findings. Wong P, Leung AN, Berry GJ, Atkins KA, Montoya JG, Ruoss SJ, Stockdale FE. AJR Am J Roentgenol. 2001; 176 (3): 718-20
Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Montoya JG, Giraldo LF, Efron B, Stinson EB, Gamberg P, Hunt S, Giannetti N, Miller J, Remington JS. Clin Infect Dis. 2001; 33 (5): 629-40
Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers. Liesenfeld O, Montoya JG, Tathineni NJ, Davis M, Brown BW, Cobb KL, Parsonnet J, Remington JS. Am J Obstet Gynecol. 2001; 184 (2): 140-5
Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS. J Infect Dis. 2001; 183 (8): 1248-53
Posttransplantation lymphoproliferative disease in heart and heart-lung transplant recipients: thirty years experience at our hospital. Chaparro S, Gao S, Perlroth M, Montoya J, Hastie T, Miller JL, Oyer PE, Schroeder J. J Heart Lung Transplant. 2001; 20 (2): 258
Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cells. Gray CM, Lawrence J, Ranheim EA, Vierra M, Zupancic M, Winters M, Altman J, Montoya J, Zolopa A, Schapiro J, Haase AT, Merigan TC. AIDS Res Hum Retroviruses. 2000; 16 (14): 1357-69
Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis. Montoya JG, Parmley S, Liesenfeld O, Jaffe GJ, Remington JS. Ophthalmology. 1999; 106 (8): 1554-63
Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced persons. Lawrence J, Schapiro J, Winters M, Montoya J, Zolopa A, Pesano R, Efron B, Winslow D, Merigan TC. J Infect Dis. 1999; 179 (6): 1356-64
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed. Zolopa AR, Shafer RW, Warford A, Montoya JG, Hsu P, Katzenstein D, Merigan TC, Efron B. Ann Intern Med. 1999; 131 (11): 813-21
Invasive fungal sinusitis due to Scedosporium apiospermum in a patient with AIDS. Eckburg PB, Zolopa AR, Montoya JG. Clin Infect Dis. 1999; 29 (1): 212-3
Risk of tuberculosis in tuberculin skin test-positive liver transplant patients. Chaparro SV, Montoya JG, Keeffe EB, Rhee JT, Small PM. Clin Infect Dis. 1999; 29 (1): 207-8
False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K, Remington JS. J Clin Microbiol. 1997; 35 (1): 174-8
Toxoplasmic myocarditis and polymyositis in patients with acute acquired toxoplasmosis diagnosed during life. Montoya JG, Jordan R, Lingamneni S, Berry GJ, Remington JS. Clin Infect Dis. 1997; 24 (4): 676-83
Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. Suzuki Y, Wong SY, Grumet FC, Fessel J, Montoya JG, Zolopa AR, Portmore A, Schumacher-Perdreau F, Schrappe M, Köppen S, Ruf B, Brown BW, Remington JS. J Infect Dis. 1996; 173 (1): 265-8
Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Montoya JG, Remington JS. Clin Infect Dis. 1996; 23 (2): 277-82
Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells. Montoya JG, Lowe KE, Clayberger C, Moody D, Do D, Remington JS, Talib S, Subauste CS. Infect Immun. 1996; 64 (1): 176-81
Preferential activation and expansion of human peripheral blood gamma delta T cells in response to Toxoplasma gondii in vitro and their cytokine production and cytotoxic activity against T. gondii-infected cells. Subauste CS, Chung JY, Do D, Koniaris AH, Hunter CA, Montoya JG, Porcelli S, Remington JS. J Clin Invest. 1995; 96 (1): 610-9
Studies on the serodiagnosis of toxoplasmic lymphadenitis. Montoya JG, Remington JS. Clin Infect Dis. 1995; 20 (4): 781-9
Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: a phase I/II study. Wood R, Montoya JG, Kundu SK, Schwartz DH, Merigan TC. J Infect Dis. 1993; 167 (3): 519-25
Measurement of HIV virus load and genotypic resistance by gene amplification in asymptomatic subjects treated with combination therapy. Holodniy M, Katzenstein D, Winters M, Montoya J, Shafer R, Kozal M, Ragni M, Merigan TC. J Acquir Immune Defic Syndr. 1993; 6 (4): 366-9
Peripheral blood mononuclear cell human immunodeficiency virus type 1 proviral DNA quantification by polymerase chain reaction: relationship to immunodeficiency and drug effect. Montoya JG, Wood R, Katzenstein D, Holodny M, Merigan TC. J Clin Microbiol. 1993; 31 (10): 2692-6
[Community practice in units of primary care at the rural level: an experience with medical students] de Bedoya YA, Casas LA, Grill H, Hoyos J, Jiménez F, Montoya JG, Torres CH. Educ Med Salud. 1984; 18 (2): 164-81